Latest Content
#263 | 7702 Update – Symetra Moves First
Nearly 2 months after the fact, we finally have our first retail product illustrations that reflect the new 7702-2% (as opposed to the old, 7702-4%) rates. The results are in-line with what I wrote about in previous articles, but I…
#262 | Inflation & Life Insurance
The picture for this post is a meme that has apparently been floating around the Reddit forums that have been instigating the surges in trading and prices of stocks, digital currencies and other commodities. Usually it’s accompanied by the caption…
#261 | The Compensation Conundrum
Now that the dust is settling on the changes to Section 7702, two big questions are starting to emerge. The first is in regards the degree to which life insurers are going to take advantage of the new latitude in…
#260 | The Hang Seng & Indexed Account Availability
Last week, Pacific Life announced that it is “pausing” allocations to its 1-Year International Indexed Account until “further notice” due to an executive order issued last year “prohibiting transactions in securities and derivatives of certain Chinese Companies.” As a result,…
#259 | Section 7702 Q&A
The Section 7702 Christmas Miracle Update It’s been a whirlwind start to the year for the life insurance industry. Since publishing The Section 7702 Christmas Miracle on January 5th, it has amassed an unbelievable 16,000 reads – a testament to…
#258 | Allianz Showcase & The Future of Illustrations
When AG 49-A was solidified over the summer, there were rumblings in the industry about rogue premium financing vendors and distribution firms planning to create their own spreadsheets to run illustrations that would not have to conform to the new…
#257 | The Section 7702 Christmas Miracle
This is the closest thing to breaking news in our industry and, as such, it’s still very much evolving. Current updates to the post are at the very bottom. For all of the buzz and lead-up to the creation and…
#256 | Symetra’s Gambit – Follow Up
In late 2013, just before I closed down the first iteration of The Life Product Review and joined MetLife, I wrote an article entitled Symetra’s Gambit. The crux of the article was that Symetra was carving out marketshare by offering…
#255 | Chronic Illness Riders: Don’t Get Tangled Up in a Lawsuit
Bobby’s Note:Over the years, I’ve been asked multiple times to cover so-called hybrid or linked-benefit life insurance products. These products are becoming incredibly popular in the market but, unfortunately, they’re not my area of core expertise and therefore I have…
#254 | AG 49-A and Allianz Life Pro+ Advantage
When it comes to product, Allianz plays a decidedly different game than many of its competitors. Rather than having a bevy of products geared towards virtually every possible application, Allianz offers just a single Indexed UL that has been gradually…
